Brandywine Global Investment Management, LLC Amarin Corp Plcuk Transaction History

Brandywine Global Investment Management, LLC

$14.2 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$2.45 - $16.27 $493,672 - $3.28 Million	-201,499 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$2.68 - $3.48 $226,331 - $293,892	84,452 Added 72.15%	201,499 $623,000
Q1 2018 May 15, 2018	BUY	$2.99 - $4.44 $349,970 - $519,688	117,047 New	117,047 $353,000

Others Institutions Holding AMRN

# of Institutions

177

Shares Held

65.1M

Call Options Held

258K

Put Options Held

98K

Sarissa Capital Management LP Greenwich, CT

24.9M
Shares

$13.2 Million
3.89% of portfolio
Kynam Capital Management, LP Princeton, NJ

12.4M
Shares

$6.58 Million
0.64% of portfolio
Eversept Partners, LP New York, NY

3.31M
Shares

$1.75 Million
0.16% of portfolio
Morgan Stanley New York, NY

2.55M
Shares

$1.35 Million
0.0% of portfolio
Scp Investment, LP

2.5M
Shares

$1.33 Million
1.16% of portfolio

View Full List

About AMARIN CORP PLCUK

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $214M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

More about AMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brandywine Global Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brandywine Global Investment Management, LLC with notifications on news.

Account